Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus
about
Evolution of resistance to a last-resort antibiotic in Staphylococcus aureus via bacterial competitionMechanisms of drug resistance: daptomycin resistanceCyclic lipodepsipeptides: a new class of antibacterial agents in the battle against resistant bacteriaFunctional linkage between genes that regulate osmotic stress responses and multidrug resistance transporters: challenges and opportunities for antibiotic discoveryWithin-host evolution of bacterial pathogens.Antimicrobial Activity of Cationic Antimicrobial Peptides against Gram-Positives: Current Progress Made in Understanding the Mode of Action and the Response of BacteriaGlucose Augments Killing Efficiency of Daptomycin Challenged Staphylococcus aureus PersistersMicrobial genomics and antimicrobial susceptibility testing.Comprehensive analysis of phospholipids and glycolipids in the opportunistic pathogen Enterococcus faecalisA novel STK1-targeted small-molecule as an "antibiotic resistance breaker" against multidrug-resistant Staphylococcus aureus.Streptococcus pyogenes polymyxin B-resistant mutants display enhanced ExPortal integrity.Evaluation of Daptomycin Non-Susceptible Staphylococcus aureus for Stability, Population Profiles, mprF Mutations, and Daptomycin ActivityComparative mechanistic studies of brilacidin, daptomycin, and the antimicrobial peptide LL16.Whole-genome analyses of Enterococcus faecium isolates with diverse daptomycin MICs.Dermabacter hominis: a usually daptomycin-resistant gram-positive organism infrequently isolated from human clinical samples.Daptomycin resistance in enterococci is associated with distinct alterations of cell membrane phospholipid contentDivergence of the SigB regulon and pathogenesis of the Bacillus cereus sensu lato group.An approach to identifying drug resistance associated mutations in bacterial strainsThe evolutionary history of amino acid variations mediating increased resistance of S. aureus identifies reversion mutations in metabolic regulatorsAdditional routes to Staphylococcus aureus daptomycin resistance as revealed by comparative genome sequencing, transcriptional profiling, and phenotypic studies.Heterogeneity of genetic pathways toward daptomycin nonsusceptibility in Staphylococcus aureus determined by adjunctive antibiotics[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].Draft Genome Sequences of Clinical Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strain APS211 and Its Daptomycin-Susceptible Progenitor APS210Mutations associated with reduced surotomycin susceptibility in Clostridium difficile and Enterococcus speciesEvolving resistance among Gram-positive pathogensImpact of daptomycin resistance on Staphylococcus aureus virulence.Stepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX gene.Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints.Differential Adaptations of Methicillin-Resistant Staphylococcus aureus to Serial In Vitro Passage in Daptomycin: Evolution of Daptomycin Resistance and Role of Membrane Carotenoid Content and Fluidity.Daptomycin-Nonsusceptible Staphylococcus aureus: The Role of Combination Therapy with Daptomycin and Gentamicin.Whole-genome analysis of a daptomycin-susceptible enterococcus faecium strain and its daptomycin-resistant variant arising during therapyBiochemical characterization of cardiolipin synthase mutations associated with daptomycin resistance in enterococci.Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall.The RpoB H₄₈₁Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus.Advances in MRSA drug discovery: where are we and where do we need to be?Effect of ester to amide or N-methylamide substitution on bacterial membrane depolarization and antibacterial activity of novel cyclic lipopeptidesA current perspective on daptomycin for the clinical microbiologist.Causal role of single nucleotide polymorphisms within the mprF gene of Staphylococcus aureus in daptomycin resistanceDaptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains.Frequency of susceptibility testing for patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.
P2860
Q24490083-3ACCCA1E-0063-428A-9AA5-EEA31DB3B64AQ26779944-9560DB2E-EE57-4CC3-B7AD-BB191271157AQ26863225-930EECBC-3A0A-4AEA-9BE6-1E27C16DF334Q27023447-D908859D-D339-4AD5-B4CD-9448E7AA02D3Q28072013-4A894874-C5A9-466A-9E30-975C635E5CD1Q28072687-24613324-04B4-4FE5-B0B3-57EB7A45667EQ28550612-1733DD31-BECA-4C2B-81AE-1EF8AE99496DQ30397574-7CA7DA0E-1B2F-466A-AA24-AB1D572BD6E9Q33579777-41B431B6-5E98-46F2-8E3F-B6B3AF5160EBQ33894853-81E31CCE-AFDA-4381-B187-AD25B4DD0440Q33899541-A4BAB658-FA64-4316-971F-D355C10054ABQ33939055-5CA90AF7-D97A-4BE1-AFDA-1C9C4BB8CDF5Q34057457-F51E9CBE-F0CD-41F2-BB92-28FAC1CC6D83Q34058150-4C948157-30AB-456E-AB73-D963C592A39EQ34286821-650C8CEE-20E1-4524-8792-1D1E7E408626Q34405922-1473F086-C32A-4CB0-9F5E-605937736658Q34453985-0392DA8C-B8BA-415A-A74C-41EC12366E4FQ34530052-6685F5CA-F77D-417B-8D61-B4A1C8BB4401Q34592835-95951EFC-1310-4B93-9947-A0467F5991D5Q34648042-DEA0577A-0C9E-49DB-82FE-727904619D0EQ35385568-5E373431-B616-48E0-BB8F-C87529103D02Q35619094-606BC873-96CD-452D-971A-5B2BFA01201AQ35722282-A306EC7C-69C8-4904-AA69-A4812754748CQ35746268-3D4A6698-1442-4D76-9653-48E20DB8A150Q35999912-EA724A26-026F-451D-850D-7B14E73CF3AAQ36147127-B8B5032F-A141-4DF6-80A0-5C600A6FA8FBQ36158472-25176974-985F-4C6F-B164-04C204F8D0FFQ36171704-B363F3C2-B2F7-45F3-8D86-4C9A923484B9Q36200018-BBA02127-E15F-4658-B239-5C21B17F7D28Q36401160-8CD8A7E0-C01B-4289-A758-366721AA3F92Q36505376-0282F511-BE56-4966-BA19-66920255DF8EQ36505466-C3296E0B-ED77-449E-9FF8-15A671B8BE8EQ36565462-3CFEF146-01CB-462B-A987-265A71D57AE8Q36787486-532B2C3C-1CDE-42B4-BCA6-839143EF49A9Q37112508-9FAF0485-1425-4187-A7EA-5AB7EE9BB586Q37209021-9C839B15-E2EB-4461-9C7F-4F3A893D0DC0Q37263289-8527E4FD-D194-4ECC-A055-66CEF44E27FBQ37263514-DB55A21D-1217-4757-9F37-808DDA7D7761Q37417749-1BAFA8EB-6036-45E6-903A-9753AB7366B3Q37546815-04404FC5-BCFF-4DB8-AEEC-5EE39BCF4899
P2860
Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Whole genome characterization ...... lates of Staphylococcus aureus
@ast
Whole genome characterization ...... lates of Staphylococcus aureus
@en
Whole genome characterization ...... lates of Staphylococcus aureus
@nl
type
label
Whole genome characterization ...... lates of Staphylococcus aureus
@ast
Whole genome characterization ...... lates of Staphylococcus aureus
@en
Whole genome characterization ...... lates of Staphylococcus aureus
@nl
prefLabel
Whole genome characterization ...... lates of Staphylococcus aureus
@ast
Whole genome characterization ...... lates of Staphylococcus aureus
@en
Whole genome characterization ...... lates of Staphylococcus aureus
@nl
P2093
P2860
P50
P3181
P1433
P1476
Whole genome characterization ...... lates of Staphylococcus aureus
@en
P2093
Aileen Rubio
David R Cameron
Doyle V Ward
George M Eliopoulos
Robert C Moellering
Spiros Miyakis
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0028316
P407
P577
2012-01-01T00:00:00Z